Active Not RecruitingNCT06769048
A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
PHASE2 · 150 planned enrolment
- Countries listed
- 2
- Registry update
- September 30, 2026
